OverviewChartNewsTraderScreen

Arch Therapeutics, Inc./  US03939W2089  /

Nasdaq Other OTC
2024-06-14  8:02:51 PM Chg. +0.0950 Volume Bid- Ask- High Low
1.0950USD +9.50% 1,112
Turnover: 1,076.5845		 -Bid Size: - -Ask Size: - 1.0950 0.9501
GlobeNewswire 05-06 Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care...
GlobeNewswire 2023-11-09 Arch Therapeutics Provides Year End Operational Update
GlobeNewswire 2023-11-02 Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care...
GlobeNewswire 2023-09-13 Arch Therapeutics Provides AC5® Commercialization Update
GlobeNewswire 2023-09-08 Arch Therapeutics Completes Financing as Bridge to Uplisting
GlobeNewswire 2022-03-14 Arch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound Syste...
GlobeNewswire 2022-01-06 Clinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex...
GlobeNewswire 2022-01-04 Arch Therapeutics Announces Appointment of Guy Fish to the Board
GlobeNewswire 2021-12-13 Arch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC...
GlobeNewswire 2021-12-01 Arch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound ...
GlobeNewswire 2021-11-01 Arch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium ...
GlobeNewswire 2021-10-25 Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAW...
GlobeNewswire 2021-10-18 Arch Therapeutics Launches Experts in Wound Care Program
GlobeNewswire 2021-10-13 Arch Therapeutics Provides Corporate Update
GlobeNewswire 2021-10-06 Arch Therapeutics to Present at the LD Micro Main Event
GlobeNewswire 2021-10-04 Arch Therapeutics Launches Coverage and Reimbursement Pilot
GlobeNewswire 2021-09-30 Arch Therapeutics Announces Appointment of Larry Hicks to the Board
GlobeNewswire 2021-09-02 Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities
GlobeNewswire 2021-07-12 Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sa...
GlobeNewswire 2021-07-07 Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 202...
GlobeNewswire 2021-06-02 Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021
GlobeNewswire 2021-05-10 Arch Therapeutics’ AC5® Advanced Wound System Presents with Recognition at the 2021 Symposium on Adv...
GlobeNewswire 2021-05-03 Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
GlobeNewswire 2021-04-27 Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SA...
GlobeNewswire 2021-04-19 Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results